Our Customer Services

ImmuNova BioMed is committed to advancing immunotherapy through cutting-edge nanotechnology. Our goal is to develop nanovaccine immunotherapy and immunomodulators that enhance the body’s natural immune response against cancer, infectious diseases, and autoimmune disorders—providing safer, more effective, and personalized treatment options.

A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
1- Custom Peptide and RNA Design

We offer design and synthesis of peptides and RNA for a variety of therapeutic, diagnostic, and research applications, including:

  • Therapeutics: Custom peptides and RNA for targeted therapy in oncology, infectious diseases, and immune disorders.

  • Diagnostics: RNA-based probes and peptides for biomarker detection and imaging

A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
2- Nanoparticle-Based Drug and RNA Delivery Systems

ImmuNova BioMed develops customized nanoparticle platforms for precise and controlled delivery of therapeutic agents, including:

  • RNA encapsulation: Advanced systems for mRNA, siRNA, or miRNA delivery with high efficiency and stability.

  • Cancer therapeutics: Targeted nanoparticles for precision drug delivery.

  • Combination therapies: Integration of RNA or peptides with therapeutic and diagnostic agents.

Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
3- Custom Nanovaccine Development

We offer comprehensive nanovaccine development services, leveraging proprietary self-assembling nanovaccine platforms. Applications include:

  • RNA-Based Vaccines: Developing mRNA vaccines for cancer, infectious diseases, and autoimmune disorders.

  • Cancer Immunotherapy: Personalized nanovaccines with tumor-specific antigens.

  • Infectious Diseases: Rapid-response vaccine development for emerging pathogens.

Service Highlights:

  • Comprehensive in silico design for peptides and RNA molecules.

  • High-purity synthesis and custom modifications (e.g., conjugations, tags).

  • RNA stability enhancement and delivery optimization.

Service Highlights:

  • Tailored formulations for RNA and drug encapsulation.

  • Controlled release profiles for optimized therapeutic effects.

  • Compatibility with various RNA types and active compounds.

A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
4- Combination Nanovaccine and Checkpoint Inhibitors

Our RNA technology services enable the development of innovative RNA therapeutics for various applications, including:

  • RNA-based immunomodulators: siRNA and miRNA for regulating immune responses in autoimmune diseases or chronic inflammation.

  • mRNA therapeutics: Customized mRNA molecules for expressing therapeutic proteins.

Service Highlights:

  • RNA design, modification, and stabilization.

  • Delivery system optimization for targeted RNA therapies.

  • Efficacy testing in preclinical models.

A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
A collection of various pills and capsules, including a prominent green gel capsule and a heart-shaped white tablet. The image has a colorful and slightly abstract presentation with a blurred, artistic style.
5- Checkpoint Inhibitor Solutions and Mimetic Peptides

Our expertise includes designing and producing custom checkpoint inhibitors and mimetic peptides for:

  • Enhancing T-cell activation in cancer immunotherapy.

  • Developing next-generation immune modulation strategies.

Service Highlights:

  • Customized checkpoint inhibitors (e.g., PD-1/PD-L1, CTLA-4 blockers).

  • RNA-based mimetic peptide expression systems.

  • Proof-of-concept and efficacy studies.

We use AI-driven technologies to create personalized treatment strategies based on patient-specific data:

  • RNA and peptide therapies tailored to individual immune profiles.

  • Predictive modeling for optimal therapy design.

Service Highlights:

  • Patient-specific RNA or peptide design.

  • Data-driven customization of treatment plans.

Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
Intricate structures resembling nanofibers or cellular formations are depicted with a blend of purple and gold hues. The surfaces are perforated with numerous small holes, creating an intricate, organic appearance. The background is a smooth gradient of dark purples, enhancing the vibrant colors of the main elements.
6- AI-Powered Personalized Therapies

Service Highlights:

  • RNA design and optimization for high immunogenicity.

  • Nanoparticle formulation and antigen/RNA loading.

  • Preclinical immunogenicity testing and optimization.

A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
A close-up view of various pills and capsules in blister packs, including brown capsules and white round tablets. The blister packs are arranged haphazardly, with some lying flat and others overlapping. The lighting highlights the shiny surface of the packaging, creating reflections.
7- Research and Development Support

We collaborate with academic and industrial partners to support cutting-edge R&D projects, including:

  • Feasibility Studies: Exploring novel RNA and peptide-based therapeutic approaches.

  • Pilot Studies: Small-scale testing of RNA and nanoparticle delivery systems.

  • Scale-Up Services: Transitioning successful concepts to clinical trials.

Service Highlights:

  • Access to advanced facilities and expertise.

  • Custom solutions for RNA and peptide-based research projects.

Contact Us

A highly detailed and magnified 3D rendering of a virus particle. The surface is spherical and covered in red spike proteins protruding from a grey core, with small orange and yellow elements scattered across.
A highly detailed and magnified 3D rendering of a virus particle. The surface is spherical and covered in red spike proteins protruding from a grey core, with small orange and yellow elements scattered across.

Reach out for inquiries about our peptide-based innovations and advanced biotechnological solutions in nanomedicine.

ImmuNovaBioMed B.V.

Pioneering peptide-based solutions for global health.

Expertise

Vision

contact@immunovabiomed.com

+31-

© 2025. All rights reserved.